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OBJECTIVE: To evaluate the expression of the cell adhesion molecules E-cadherin and N-cadherin and the
transcription factor Snail in invasive ductal breast carcinomas and to determine their relationships with
clinicopathological features.
METHODS: Immunohistochemistry was used to examine E-cadherin, N-cadherin, and Snail protein expression in 132
invasive breast carcinomas.
RESULTS: The expression of E-cadherin was decreased (negative or weak) in 37.1% of invasive carcinomas, while N-
cadherin and Snail overexpression were detected in 51.9% and 40.9% of carcinomas, respectively. Low E-cadherin
expression was significantly correlated with poorly differentiated carcinoma (53.1%), positive node status (80.9%),
poor Nottingham Prognostic Index (64.7%), and the presence of estrogen and progesterone receptors.
Overexpression of N-cadherin and Snail were also significantly correlated with poorly differentiated carcinoma,
positive node status, and poor Nottingham Prognostic Index but were correlated with the absence of hormone
receptors. Loss of E-cadherin immunoexpression was strongly associated with the presence of membranous N-
cadherin (87.8%) and nuclear Snail (69.4%).
CONCLUSION: Loss of E-cadherin and overexpression of N-cadherin and Snail in breast carcinomas may play a central
role in the development of invasive ductal breast carcinoma. These biomarkers may provide a valuable reference for
the study of invasive ductal carcinoma progression and to characterize the biological behavior of the tumor. In the
future, increased N-cadherin and decreased E-cadherin expression may be used as indicators of the progression and
prognosis of invasive ductal carcinoma.
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INTRODUCTION
Breast cancer is the most common cancer among Egyptian
women. According to the most recent (2007) registry of the
Egyptian National Cancer Institute, breast cancer represents
34.26% of female cancers.1
Embryonic development, tissue remodeling, restitution
and wound repair are key biological processes that require
epithelial cells to escape from the rigid structural constraints
of their tissue architecture and achieve cell migration and
movement. The epithelial–mesenchymal transition (EMT) is
a fundamental and highly conserved process that achieves
this morphogenetic transformation.2,3 The progression of
breast cancer is often accompanied by changes in the pattern
of gene expression of neoplastic cells, resulting in a highly
tumorigenic and invasive cell phenotype. Some of these
changes are reminiscent of EMT, as they result in a loss of
epithelial features and a gain of mesenchymal properties.4 In
epithelial tumors, changes in the profile and activity of
adhesion molecules accompany malignant progression.5 E-
cadherin, the prototypical adhesion molecule expressed in
epithelial cells, is frequently lost in epithelial malignancies,
whereas N-cadherin, which is absent in normal epithelia, is
up-regulated in many invasive tumors.5-8 In aggressive
tumors, EMT is characterized by reduced E-cadherin and
increased N-cadherin expression, contributing to a stroma-
oriented cellular adhesion profile, increased tumor cell
motility and other invasive properties.9 Thus, the localized
occurrence of EMT allows the tumor to progress to invasive
Copyright  2011 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
CLINICS 2011;66(10):1765-1771 DOI:10.1590/S1807-59322011001000015
1765
cancer andmetastatic disease.10,11 In human breast cancer, N-
cadherin is up-regulated in invasive ductal carcinomas and is
further increased in tumors with metastatic potential.12
Snail belongs to the conserved Snail superfamily of
transcription factors, which are expressed at different stages
of development in different tissues.13 Recently, Snail has
been implicated in the progression of human tumors via its
regulation of E-cadherin.14 Specifically, Snail interacts with
proximal E-boxes of the E-cadherin promoter to suppress its
expression.15 Such transcriptional repression mechanisms
have emerged as one of the crucial processes underlying the
down-regulation of E-cadherin expression during develop-
ment and tumor progression.
The main aim of this study was to evaluate whether E-
cadherin, N-cadherin, and Snail expression could be used as
markers of the progression of invasive ductal breast
carcinoma. To this end, we investigated the correlations
between the expression of these proteins and different
clinicopathological variables in 132 cases of primary
invasive ductal breast carcinoma.
MATERIAL AND METHODS
Formalin-fixed and paraffin-embedded tissue blocks of
tumor samples from 132 patients diagnosed with invasive
ductal breast carcinoma (IDC) at the Pathology Department
of Minia University Hospital between 2007 and 2009 were
included in this study. All carcinomas were ductal not
otherwise specified, and 54 were characterized as ductal
carcinoma in situ (DCIS) associated with invasive carci-
noma. All cases were reviewed by H. M. Abd Elmoneim to
confirm the diagnosis. The characteristics of these retro-
spective cohorts are detailed in Table 1. Patients were only
enrolled in the study if paraffin blocks suitable for
immunohistochemistry were available and adequate clinical
parameters had been collected. Histologic type and grade
for invasive cases were defined according to the WHO and
modified Scarf-Bloom-Richardson classifications, respec-
tively.16 Tumor staging was performed according to the
Tumor, Node, Metastasis (TNM) system of the International
Union Against Cancer.17
Nottingham Prognostic Index (NPI)
This index has been validated as a measure of breast
cancer prognosis and incorporates tumor grade, tumor size,
and number of involved axillary lymph nodes. These three
items are expressed as scores that are added together.
Prognosis is favorable if NPI is #3.5, intermediate if .3.5
but ,5.5 and poor if$ 5.5. NPI values were calculated for
132 carcinomas.
Immunohistochemical staining
A streptavidin–biotin immunoperoxidase complex proce-
dure was used for staining. Formalin-fixed, paraffin-
embedded samples (4 mm thick) were deparaffinized and
rehydrated, and endogenous peroxidase activity was
blocked with 3% H2O2 in methanol for 30 minutes.
Antigen retrieval was carried out by microwave treatment
in sodium citrate buffer (0.01 M, pH 6.0) for 10 minutes.
Incubation with primary antibody was performed for E-
cadherin (clone M3612, diluted 15400; DAKO), N-cadherin
(clone M3613, diluted 1525; DAKO), Snail (clone CE2C3,
diluted 15100, Santa Cruz, CA, USA), estrogen receptor (ER)
(clone 1D5, diluted 15100; DAKO), and progesterone
receptor (PR) (clone 636, diluted 15100; DAKO) for 2 hours,
followed by incubation with biotinylated secondary anti-
body for 30 minutes at room temperature. Slides were
developed with diaminobenzidine (Sigma, USA). Finally,
sections were counterstained with hematoxylin, dehy-
drated, cleared, and mounted. Each batch of staining
included a negative control section treated with phos-
phate-buffered saline (PBS) instead of primary antibodies.
Immunohistochemical evaluation
ER and PR expression were scored from 0 to 2 as follows:
0 (negative): less than 5% of nuclei stained; 1 (borderline): 5–
19% of nuclei stained; 2 (positive): more than 20% of nuclei
stained.18
E-cadherin and N-cadherin expression were classified on
the basis of the intensity of staining, the portion of the
circumference of the cytoplasmic membrane stained and the
percentage of cells exhibiting membranous staining. Grade
0: negative (no membranous staining identified); 1+: weak
(faint staining involving a portion of the circumference of
the cytoplasmic membrane in at least 10% of neoplastic
cells); 2+: positive (moderate to definitive staining of the
membrane over 100% of the cytoplasmic circumference in at
least 10% of neoplastic cells); 3+: positive (strong positive
staining of the membrane over 100% of the cytoplasmic
circumference in at least 10% of neoplastic cells). For
practical and statistical purposes, we grouped the weakly
Table 1 - Clinicopathological data of 132 invasive ductal
breast carcinoma patients.
Clinicopathologic characteristics
No. (%)
n=132
Age (y)
,50 years
$50 years
52 (39.4%)
80 (60.6%)
Histology
IDC
IDC + DCIS
78 (59.1%)
54 (40.9%)
Tumor size
#2 cm
2-5 cm
.5 cm
15 (11.4%)
82 (62.1%)
35 (26.5%)
Grading
I
II
III
10 (7.6%)
58 (43.9%)
64 (48.5%)
Lymph node status
Negative
1-3 positive
.3 positive
51 (38.6%)
31 (25.8%)
47 (35.6%)
Staging
I
II
III
13 (9.8%)
70 (53%)
49 (37.2%)
NPI
Favorable
Moderate
Poor
16 (12.1%)
48 (36.4%)
68 (51.5%)
ER status
Negative
Positive
64 (48.5%)
68 (51.5%)
PR status
Negative
Positive
67 (50.8%)
65 (49.2%)
NPI: Nottingham Prognostic Index; ER: estrogen receptor; PR;
progesterone receptor.
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positive and negative cases together. Cases graded as
moderate and strongly positive were considered positive
tumors.19
Immunostaining with Snail produced cytoplasmic back-
ground staining in some cells, but only cells with nuclear
protein accumulation indicative of transcriptional activity
were considered positive. The sample was evaluated as
positive, independently of intensity, if Snail was observed in
.10% of nuclei. Cells that showed both nuclear and
cytoplasmic staining were classified as positive for nuclear
expression, in accordance with earlier studies.20
Statistical analysis
Statistical analysis was performed using SPSS 16.0 for
Windows (SPSS Inc., Chicago, IL). The chi-square test was
performed to determine the correlations between clinico-
pathological parameters and protein expression. The
Spearman’s rho pairwise bivariate correlations test was
used to estimate the relationships between the observed
staining patterns. Results were considered significant at
p#0.05.
RESULTS
Population and tumor characteristics
Patient age ranged from 39 to 71 years (mean 52.67,
standard deviation 8.188). The clinicopathological charac-
teristics of the patients are summarized in Table 1.
There was no significant correlation between the expres-
sion of any protein studied and age group or histological
type (intraductal or invasive).
As shown in Figure 1, the intercellular borders of the
luminal cells of normal glandular structures present in
breast carcinoma specimens were strongly stained by E-
cadherin. The myoepithelial cells of ducts and ductules
showed much weaker or negative staining at cell–cell
borders. Intraductal portions of IDCs showed strong
staining for E-cadherin. A total of 37.1% of samples had
lost E-cadherin expression (negative or weak). The absence
of E-cadherin protein was significantly associated with all
adverse clinicopathological variables. Negative E-cadherin
expression was observed in 10% of grade I, 24.1% of grade
II, and 53.1% of grade III tumors. There was a significant
difference in E-cadherin down-regulation between grading
groups (p= 0.001). A reduction in E-cadherin expression was
detected in 49% of samples from the negative lymph node
group and 80.9% of samples from the .3 positive lymph
nodes group. There was a significant correlation between E-
cadherin expression and lymph node group (p,0.001).
Overall, 64.7% of the samples that were negative for E-
cadherin immunoexpression were associated with poor NPI
status (p,0.001). The absence of E-cadherin was also
associated with positive expression of ER and PR (p,0.01
and 0.001 respectively) (Table 2).
As shown in Figure 2, normal breast ducts were negative
for N-cadherin expression. Positive membranous expression
(51.9% of cases) was associated with poor histologic
differentiation. A significant correlation was found between
N-cadherin expression and grading group (p= 0.001). N-
cadherin expression was detected in 70% of grade I, 34.5%
of grade II, and 65.6% of grade III samples. Similarly, 21.6%
of samples from the negative lymph node group and 78.7%
of samples from the .3 positive lymph nodes group were
positive for N-cadherin expression (p,0.001). N-cadherin
expression (75%) was associated with poor NPI status
(p,0.001). A significant inverse association between mem-
branous expression of N-cadherin and positive hormone
receptor status was also detected (Table 2).
Snail (Figure 3): It was negative in normal glandular
structures present within breast carcinoma. Snail was
detected in 40.9% of total numbers of tumors. A significant
correlation exists between Snail expression and tumor
grade, with increased Snail expression observed with
increasing tumor grade. More than half of grade III tumors
(56.2%) expressed Snail, while 20% and 27.6% of grade I and
II tumors exhibited nuclear Snail expression. Snail was
frequently detected in node-positive tumors (44.1%) and
less frequently detected in node-negative tumors (15.7%)
(p,0.001). Snail expression (61.8%) was frequently observed
in samples with poor NPI values (p,0.001). We also found a
statistically significant correlation between Snail expression
and negative ER and PR levels (Table 2).
Relationship among E-cadherin, N-cadherin and
Snail expression in IDCs
Weak expression of membranous E-cadherin was
strongly associated with the presence of membranous N-
cadherin (87.8%) (p,0.001) and nuclear Snail (69.4%)
(p,0.001). A significant association was observed between
nuclear Snail expression and the absence of membranous E-
cadherin (p,0.001; correlation coefficient -0.445). Positive
associations were also observed between N-cadherin over-
expression and the absence of membranous E-cadherin
(p,0.001; correlation coefficient -0.546) and the presence of
nuclear Snail (p,0.001; correlation coefficient -0.456)
(Table 3).
DISCUSSION
Various signaling molecules and transcription factors
regulate the expression of E-cadherin. Loss of E-cadherin
induces epithelial–mesenchymal transition in several can-
cers, leading to increased tissue mobility and tumor
invasion.21 In our study, E-cadherin was lost in 37.1% of
tumors. Loss of E-cadherin–mediated cell adhesion is one of
the key mechanisms involved in the metastatic conversion
of epithelial cells and EMT.22,23 Partial or complete loss of E-
cadherin is often correlated with an unfavorable prognosis,
confirming that E-cadherin is important for maintaining the
epithelial state.24,25 Furthermore, a significant correlation
was found between the loss of E-cadherin and tumor
grading group, lymph node group, and poor NPI status.
The association of E-cadherin down-regulation with tumor
grade has also been shown in other studies, although
published results have been somewhat inconsistent;25,26 E-
cadherin expression showed a significant relationship with
lymph node metastases in one study,27 while it was
independent of lymph node status in another.25 We also
found associations between E-cadherin expression and ER
and PR expression, in accordance with another study.25 ER-
positive tumors express normal amounts of E-cadherin
protein, and the loss of ER and E-cadherin genes has been
linked to disease progression in invasive carcinomas of the
breast. However, in another study, E-cadherin expression
was not associated with a positive ER or PR status.28
In the present study, positive membranous expression of
N-cadherin was detected in 51.9% of invasive ductal breast
carcinoma samples and was associated with poor histologic
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Figure 1 - (A) Immunohistochemical expression of E-cadherin was detected in normal breast glands. The luminal cells of the terminal
ductules exhibit cytoplasmic membrane (linear intercellular) immunoreactivity, while no staining of the myoepithelial cells at the basal
side of the epithelium was observed (X 400). (B) Immunohistochemical staining for E-cadherin in invasive ductal carcinomas of the
breast. A well-differentiated tumor (grade I) showing strong cytoplasmic membrane staining localized almost exclusively to areas of
cell–cell junctions is shown (X 400). (C) Poorly differentiated infiltrating ductal breast carcinomas (grade III) immunostained for E-
cadherin, showing reduced and heterogeneous staining (X 400).
Table 2 - Expression of E-cadherin, N-cadherin and Snail in 132 invasive ductal breast carcinomas and their correlations
with clinicopathological features.
E-cadherin N-cadherin Snail
Data Negative (%) P ositive (%) p-value Negative (%) Positive (%) p-value Negative (%) Positive (%) p-value
n=132 49 (37.1) 83 (62.9) 63 (47.7) 69 (51.9) 78 (59.1) 54 (40.9)
Age
,50 years
$50 years
19 (36.5)
30 (37.5)
33 (63.5)
50 (62.5)
0.9 22 (42.3)
41 (51.2)
30 (51.2)
39 (48.8)
0.3 30 (57.7)
48 (60)
22 (42.6)
32 (40)
0.7
Tumor size
#2 cm
2-5 cm
.5 cm
1 (6.7)
28 (34.1)
20 (57.1)
14 (93.3)
54 (65.9)
15 (42.9)
0.002 11 (73.3)
41 (50)
11 (31.4)
4 (26.7)
41 (50)
24 (68.6)
0.02 14 (93.3)
47 (57.3)
17 (48.6)
1 (6.7)
35 (42.7)
18 (51.4)
,0.01
Histology
IDC
IDC+DCIS
30 (38.5)
19 (35.2)
48 (61.5)
35 (64.8)
0.7 35 (44.9)
28 (51.9)
43 (55.1)
26 (48.1)
0.4 48 (61.5)
30 (55.6)
30 (38.5)
24 (44.4)
0.4
Grade
Grade I
Grade II
Grade III
1 (10)
14 (24.1)
34 (53.1)
9 (90)
44 (39.7)
30 (46.9)
0.001 3 (30)
38 (65.5)
22 (34.4)
7 (70)
20 (34.5)
42 (65.6)
0.001 8 (80)
42 (72.4)
28 (43.8)
2 (20)
16 (27.6)
36 (56.2)
0.002
LN status
Negative
1-3 positive
. 3 positive
2 (49)
9 (26.5)
38 (80.9)
49 (96.1)
25 (73.5)
9 (19.1)
,0.001 40 (78.4)
13 (38.2)
10 (21.3)
11 (21.6)
21 (61.8)
37 (78.7)
,0.001 43 (84.3)
19 (55.9)
16 (34)
8 (15.7)
15 (44.1)
31 (66)
,0.001
Stage
I
II
III
1 (7.7)
10 (14.3)
38 (77.6)
12 (92.3)
60 (85.7)
11 (22.4)
,0.001 10 (76.9)
46 (65.7)
7 (14.3)
3 (23.1)
24 (34.3)
42 (85.7)
,0.001 12 (92.3)
50 (71.4)
16 (32.7)
1 (7.7)
20 (28.6)
33 (67.3)
,0.001
NPI
Favorable
Moderate
Poor
0 (0)
5 (10.4)
44 (64.7)
16 (100)
43 (89.6)
24 (35.3)
,0.001 11 (68.8)
35 (72.9)
17 (25)
5 (31.2)
13 (27.1)
51 (75)
,0.001 15 (93.8)
37 (77.1)
26 (38.2)
1 (6.2)
11 (22.9)
42 (61.8)
,0.001
ER status
Negative
Positive
36 (56.2)
13 (19.1)
28 (43.8)
55 (80.9)
,0.001 22 (34.4)
41 (60.3)
42 (65.6)
27 (39.7)
0.001 24 (37.5)
54 (79.4)
40 (62.5)
14 (20.6)
,0.001
PR status
Negative
Positive
35 (52.2)
14 (21.5)
32 (47.8)
51 (78.5)
0.001 25 (37.3)
38 (58.5)
42 (62.7)
27 (41.5)
0.01 28 (41.8)
50 (76.9)
39 (58.2)
15 (23.1)
0.001
LN: lymph node; NPI, Nottingham Prognostic Index; ER: estrogen receptor; PR, progesterone receptor. Test of significance: chi-square test. P-values #0.05
are considered statistically significant.
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differentiation. N-cadherin expression was increased in
samples from patients with high tumor grade, poor NPI,
positive lymph node infiltration and negative hormone
receptors. High levels of N-cadherin expression are
observed in most high-grade invasive ductal carcinomas,
and N-cadherin is increased further in metastasizing
subtypes, such as micropapillary breast cancers.12 This is
in agreement with other studies, which have reported that
N-cadherin expression is significantly higher in poorly
differentiated carcinomas than in moderately or well-
differentiated invasive ductal carcinomas.25,29 N-cadherin
expression is detected in pre-invasive lesions, suggesting
that increased N-cadherin expression may be involved
in the transition from intraductal to invasive carcinoma.
Figure 2. (A) N-cadherin overexpression in poorly differentiated invasive ductal carcinomas (grade III) showed positive cytoplasmic
membrane staining for N-cadherin. Normal breast duct was negative for N-cadherin (upper right side) (X 400). (B)
Immunohistochemical staining for N-cadherin in moderately differentiated invasive ductal carcinomas of the breast (grade II).
Tumor cells show strong cytoplasmic membrane staining localized near cell–cell junctions (X 400). (C) Immunohistochemical staining for
N-cadherin in invasive duct carcinomas of the breast. This poorly differentiated tumor (grade III) shows strong cytoplasmic membrane
staining (X 400).
Figure 3 - (A) Immunohistochemical staining for Snail demonstrates strong nuclear localization in ductal carcinoma in situ of the breast
(cribriform and solid types). The upper right side of the figure shows negative staining for Snail in normal human mammary gland
lobules (X 200). (B) Immunohistochemical staining for Snail demonstrating nuclear localization in well-differentiated invasive ductal
carcinomas of the breast (grade I). (X 400). (C) Immunohistochemical staining for Snail in invasive ductal carcinomas of the breast. This
poorly differentiated tumor (grade III) exhibits strong nuclear staining (X 400).
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Thus, N-cadherin is associated with tumor aggressiveness
and metastatic potential and may contribute to tumor
progression.12,30
In our samples, Snail showed increased nuclear expres-
sion with increasing tumor grade. A relationship between
Snail expression and cell differentiation has also been
observed both in vitro and during early embryonic devel-
opment.31,32 In addition, a correlation between Snail
expression and lymph node status was detected in our
study, i.e., Snail increased in node-positive tumors and
decreased in node-negative tumors. This is in agreement
with previous results, which showed that Snail expression
correlates with the presence of lymph node metastases in
IDCs. Snail was expressed in all IDCs with lymph node
metastases, and all Snail-negative tumors were node-
negative. Snail expression in epithelial cells induces not
only profound changes in cell morphology but also the
acquisition of tumorigenic and invasive properties. It has
been concluded that Snail is involved in the progression of
breast ductal carcinoma and may therefore serve as a
marker of metastatic potential.33 We also found that Snail
expression was significantly increased in samples with poor
NPI status. In a recent study, no association was found
between Snail and any poor prognostic factors.34 This
contradicts previous findings that reported an association
among Snail, poor prognostic factors and the presence of
metastasis.32,33,35 Here, we found statistically significant
correlations between Snail and ER and PR protein expres-
sion levels. Snail is a repressor that down-regulates the
expression of aromatase (estrogen synthetase) in healthy
breast tissue.33 It has been suggested that Snail may have a
protective role against cancer in healthy breast tissue.36
Transcriptional silencing can cause reduced expression of
E-cadherin.37 Interestingly, zinc finger transcription factors
such as Snail are important for the epithelial–mesenchymal
transition in embryonic development, during which E-
cadherin expression is lost. Experimental knockdown of E-
cadherin in epithelial breast cancer cell lines has confirmed
that E-cadherin acts as a tumor suppressor.38,39 Our results
reveal a significant association between the nuclear expres-
sion of Snail and the loss of membranous E-cadherin.
Analyses of different mechanisms for E-cadherin inactiva-
tion in breast ductal carcinomas have shown that Snail is
expressed in primary human tumors. A correlation between
Snail expression and a reduction or lack of E-cadherin
expression has been detected in a large number of
tumors.32,33
Here, we have shown that N-cadherin expression is asso-
ciated with a loss of membranous E-cadherin (correlation
coefficient -0.546). Recent evidence indicates that N-
cadherin is expressed in highly invasive tumor cell lines
that lack E-cadherin expression. These findings raise the
possibility that N-cadherin contributes to the invasive
phenotype.40 Cadherin switching from E- to N-cadherin in
epithelial malignancies has often been attributed to a switch
from an epithelial to a mesenchymal phenotype,4 and this
cadherin switching is an important event in cancer
progression.41 Importantly, cadherin switching has an
independent prognostic effect on time to biochemical failure
and clinical recurrence in multivariate survival analyses,
and this effect was stronger than that of either E-cadherin or
N-cadherin alone.9 Consistent with our findings, a recent
study of soluble E-cadherin and N-cadherin as serum
biomarkers in prostate cancer showed that an increased
level of N-cadherin is a marker of ongoing EMT and tumor
progression.42,43
Down-regulation of E-cadherin and up-regulation of N-
cadherin both occur at the transcriptional level. However,
neither experimental knockdown nor experimental over-
expression of N-cadherin interfered with morphological
changes. In addition, the morphological changes associated
with EMT preceded the down-regulation of E-cadherin.44
Up-regulation of N-cadherin in epithelial tumor cells
contributes to the invasive/metastatic phenotype.12,45
In summary, our results indicate that N-cadherin is up-
regulated in invasive ductal carcinoma of the breast. Loss of
E-cadherin immunoexpression correlates significantly with
tumor grade and other prognostic factors. N-cadherin
expression in ductal breast carcinomas correlates with
tumor aggressiveness, suggesting that cadherins could be
useful for breast cancer diagnosis. Our present data strongly
suggest the importance of EMT featuring increased N-
cadherin and decreased E-cadherin expression in the
progression and prognosis of patients with invasive ductal
carcinoma. This switch is common and may be at least
partly mediated by aberrant expression of Snail.
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